Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from BAX

How Is Baxter International's Stock Performance Compared to Other Medical Devices Stocks?

Baxter International has lagged behind its peers in the medical devices industry over the past three months, and analysts are cautious about the stock's prospects.

Baxter International Stock: Analyst Estimates & Ratings

Baxter International Stock: Analyst Estimates & Ratings

Due to Baxter International’s underperformance relative to the broader market over the past year, Wall Street analysts remain cautious about the stock’s prospects.

Baxter International's Quarterly Earnings Preview: What You Need to Know

Baxter International's Quarterly Earnings Preview: What You Need to Know

Baxter International is all set to announce its third-quarter results next month, with analysts predicting a double-digit growth in the company's earnings.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Baxter Stock: Is BAX Underperforming the Healthcare Sector?

Baxter has underperformed the healthcare sector over the past year, and analysts are cautious about the stock’s prospects.

Is Becton, Dickinson, and Company Stock Underperforming the Nasdaq?

Becton, Dickinson, and Company have recently underperformed in the Nasdaq, but Wall Street analysts are optimistic about the stock’s prospects.

3 High-Growth MedTech Stocks to Buy

The medtech industry’s long-term growth is fueled by growing demand for medical devices, adoption of cutting-edge technologies, and improved efficiency. Thus, it could be ideal to buy fundamentally solid medtech stocks Baxter International (BAX), Zimmer Biomet Holdings (ZBH), and Embecta (EMBC) poised for substantial growth. Keep reading.

Do Wall Street Analysts Like Baxter International Stock?

As Baxter International has underperformed the broader market over the past year, Wall Street analysts remain cautious about the stock's prospects.

inkl

Read news from The Economist, FT, and more,
with one subscription

Baxter International's Q2 2024 Earnings: What to Expect

Baxter International's Q2 2024 Earnings: What to Expect

Baxter International is poised to release its second-quarter results this month, and analysts are projecting a double-digit earnings growth.

3 Growth Stocks With P/E Ratios Below Industry Average

3 Growth Stocks With P/E Ratios Below Industry Average

Growth stocks trading at lower P/E ratio than the industry average can be a suitable investment choice. Top picks now could be Cardinal Health (CAH), Baxter International (BAX), and DocuSign (DOCU). Keep reading.

Is Becton, Dickinson and Company Stock Underperforming the S&P 500?

Is Becton, Dickinson and Company Stock Underperforming the S&P 500?

Becton, Dickinson and Company has lagged the S&P 500 recently, but analysts are optimistic about the stock’s prospects.

Baxter International Stock Outlook: Is Wall Street Bullish or Bearish?

Baxter International Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Baxter International’s relatively underwhelming performance over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Analyst Ratings for Baxter Intl

Analyst Ratings for Baxter Intl

Analysts have provided the following ratings for Baxter Intl (NYSE:BAX) within the last quarter:

Baxter's FDA Review For Novum IQ Large Volume Pump Put On Hold, Lowers FY22 EPS Outlook

Baxter's FDA Review For Novum IQ Large Volume Pump Put On Hold, Lowers FY22 EPS Outlook

Baxter International Inc (NYSE:BAX) has posted Q1 revenue of $3.71 billion, beating the consensus of $3.68 billion, up 26% on a reported basis, 29% on a constant currency basis, and 3% on an operational basis. Adjusted EPS of $0.93 increased 22%, ahead of the consensus of $0.80. Baxter's newly acquired Hillrom businesses…

Recap: Baxter Intl Q1 Earnings

Recap: Baxter Intl Q1 Earnings

Baxter Intl (NYSE:BAX) reported its Q1 earnings results on Thursday, April 28, 2022 at 07:15 AM. Here's what investors need to know about the announcement.

Get all your
news in one place.

100’s of premium titles.
One news app.

Death Cross Looms Over Baxter Intl Investors

If history is any guide, there may be trouble ahead for shares of Baxter Intl (NYSE:BAX). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

FDA Issues To Class I Recall To Baxter's Spectrum Infusion Pump

In December 2021, Baxter International Inc (NYSE: BAX) issued an urgent safety communication about an issue with some of its Spectrum infusion pumps.

Analyst Ratings For Baxter Intl

Over the past 3 months, 6 analysts have published their opinion on Baxter Intl (NYSE:BAX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Stabilize Your Portfolio with These 5 High-Quality Stocks

The stock indices are down, heading for a second straight losing week on investor concerns about geopolitical tensions and the Fed’s actions. And the market is expected to remain volatile in the near term. Hence, we think high-quality stocks Merck & Co. (MRK), Archer-Daniels-Midland (ADM), Baxter (BAX), McKesson (MCK), and…

Get all your
news in one place.

100’s of premium titles.
One news app.

Baxter Clocks Better-Than-Expected Q4 Earnings, But FY22 Guidance Trail Street View

Baxter International Inc (NYSE: BAX) has posted Q4 revenue

Recap: Baxter Intl Q4 Earnings

Baxter Intl (NYSE:BAX) reported its Q4 earnings results on Thursday, February 17, 2022 at 07:15 AM. Here's what investors need to know about the announcement.

Baxter International vs. Becton Dickinson: Which Medical Equipment & Supply Stock is a Better Buy?

The demand for medical equipment & supplies is rising exponentially with the emergence of severe illnesses such as the ongoing Coronavirus pandemic and the growing elderly population. So, Baxter International (BAX) and Becton Dickinson and Company (BDX) should benefit. But which of these two stocks is a better buy now?…

Organisations

US Federal Reserve

Cardinal Health Inc

Becton Dickinson

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Topics

Medical Technology

inkl

Read news from The Economist, FT, and more,
with one subscription

Places

249,608 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play